Brenntag Specialties Pharma offering phosphate-based excipients by Budenheim
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
Ukhade brings deep expertise in large-scale infrastructure planning, cross-functional leadership, and project innovation.
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Xtandi is approved in over 80 countries, including the U.S., EU, and Japan
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
The facility will manufacture 13,200 MTPA Benzyl Chloride, 9,600 MTPA Benzyl Alcohol, and 7,200 MTPA Benzaldehyde
The collaboration aims to enhance the accuracy of physics-based methods with AI models for optimising small molecule medicine discovery and development
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
Subscribe To Our Newsletter & Stay Updated